Big Pharma leading in access-to-medicine strategies, shows data
The 2022 Access to Medicine Index shows all 20 pharma companies have an over-arching access to medicine strategy, benefitting low and middle-income countries.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
